Alcohol Use Disorder clinical trials
Showing 101–150 of 222 active trials. Describe your situation to see which ones you may be eligible for.
- Understanding Pathways to Wellness and Recovery in Detroit - Digital Recovery Support Services
- Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training
- SMART-r: Substance Monitoring and Active Relapse Tracking Repository
- Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
- Smartphone-based Intervention for Young Adults With ADHD
- Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974
- Hepatic Lipid Metabolism-Alcohol Use Disorder
- Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery
- Understanding the Associations Between Romantic Relationship Conflict, Psychophysiological Responding and Alcohol Misuse Among Emerging Adults
- Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
- The Impact of Heavy Alcohol Use on Saliva and Oral Health
- Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
- Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat
- COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study
- NIAAA Natural History Protocol
- Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
- Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic
- Emergency Medicine Peer Outreach Worker Engagement for Recovery
- Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
- Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
- Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
- Imaging CRF X NOP Interactions in Alcohol Use Disorder
- Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
- Spironolactone in Alcohol Use Disorder (SAUD)
- Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder
- A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
- Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment
- Developing a Novel Human Laboratory Paradigm for AUD Medication Screening
- Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms
- Anxiety During Abstinence in AUD
- DEVELOPMENT OF A NOVEL PEER RECOVERY SUPPORTER TRAINING PLATFORM
- Neural and Hormonal Influences on Sex Differences in Risk for AUD
- The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
- Probenecid Administration for Alcohol Craving and Consumption
- Centralized Virtual SBIRT for Pediatric Primary Care
- Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
- Environment and Alcohol: A Pilot Study
- Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study
- Impulsivity Domains and Subjective Response
- Enhancing Prospective Thinking in Early Recovery (BEAM)
- Cerebellar Involvement in Alcohol Use Disorder (AUD)
- Advancing Couple and Family Alcohol Treatment Through Patient-Oriented Research and Mentorship
- Neural Correlates During Alcohol Intoxication
- Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
- Combining a Smartphone App With Medications to Manage Heavy Drinking
- Ketone Ester Intervention in Alcohol Use Disorder
- Suvorexant and Alcohol
- Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
- Drinking, Acetate, and Stress
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.